尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Sun Elaine D. Director active across 2 companies, notably Recursion Pharmaceuticals, INC.. Cumulatively, 6 disclosures have been recorded. History available since 26 May 2023. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Sun Elaine D is a declarant and appears in 6 filings in total. In the sampled recent filings, the period runs from 2023-05-31 to 2026-02-10, the modal transaction nature is Attribution, and the companies mentioned are Dynavax Technologies CORP and Recursion Pharmaceuticals, INC., where she is a Director.